CS and neoplasm: AT101 leads to potent local activation of CS on the cell surface, causing lysis of cancer cells and recruitment of NK cells and macrophages to the tumor microenvironment, ultimately leading to a significant reduction in PDAC tumor growth and increasing survival of all treated mice.